BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20445835)

  • 1. Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate.
    Williams ED; Reimherr FW; Marchant BK; Strong RE; Halls C; Soni P; Gale PD; Robison RJ
    Ann Clin Psychiatry; 2010 May; 22(2):84-93. PubMed ID: 20445835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.
    Robison RJ; Reimherr FW; Gale PD; Marchant BK; Williams ED; Soni P; Halls C; Strong RE
    Ann Clin Psychiatry; 2010 May; 22(2):94-102. PubMed ID: 20445836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD.
    Reimherr FW; Marchant BK; Williams ED; Strong RE; Halls C; Soni P
    Ann Clin Psychiatry; 2010 May; 22(2):103-12. PubMed ID: 20445837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
    Marchant BK; Reimherr FW; Halls C; Williams ED; Strong RE
    Ann Clin Psychiatry; 2010 Aug; 22(3):196-204. PubMed ID: 20680193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary comparative study of the personality disorder evaluation DIP instrument with the semi-structured SCID-II interview].
    Massoubre C; Bonnefond H; Grosselin A; Nelva A; Pellet J; Lang F
    Encephale; 2009 Dec; 35(6):544-53. PubMed ID: 20004285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
    Levin FR; Evans SM; Brooks DJ; Garawi F
    Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
    Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P; Sever J; Zalsman G; Weizman A
    Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Biederman J; Mick E; Surman C; Doyle R; Hammerness P; Harpold T; Dunkel S; Dougherty M; Aleardi M; Spencer T
    Biol Psychiatry; 2006 May; 59(9):829-35. PubMed ID: 16373066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate.
    Buitelaar JK; Sobanski E; Stieglitz RD; Dejonckheere J; Waechter S; Schäuble B
    J Clin Psychiatry; 2012 Aug; 73(8):1097-102. PubMed ID: 22780962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personality Disorder in Adult Attention-Deficit/Hyperactivity Disorder: Attrition and Change During Long-term Treatment.
    Gift TE; Reimherr FW; Marchant BK; Steans TA; Wender PH
    J Nerv Ment Dis; 2016 May; 204(5):355-63. PubMed ID: 27082828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of comorbid personality disorders in bipolar and unipolar affective disorders.
    Brieger P; Ehrt U; Marneros A
    Compr Psychiatry; 2003; 44(1):28-34. PubMed ID: 12524633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attention deficit disorder: multidisciplinary observational study over 1 year].
    Chambry J; Billard C; Guinard M; Lacaze E; Idiart ME; Delteil-Pinton F; Cohen de Lara A
    Encephale; 2011 Jun; 37(3):180-90. PubMed ID: 21703433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T; Doyle R; Surman C; Prince J; Mick E; Aleardi M; Herzig K; Faraone S
    Biol Psychiatry; 2005 Mar; 57(5):456-63. PubMed ID: 15737659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spanish version of the Wisconsin Personality Disorders Inventory-IV (WISPI-IV): tests of validity and reliability.
    Smith TL; Klein MH; Alonso C; Salazar-Fraile J; Felipe-Castaño E; Moreno CL; Acosta SR; Rios LI; Martí-Sanjuán V
    J Pers Disord; 2011 Dec; 25(6):813-33. PubMed ID: 22217227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of axis II disorders in adolescents: a cluster- and factor-analytic investigation of DSM-IV categories and criteria.
    Durrett C; Westen D
    J Pers Disord; 2005 Aug; 19(4):440-61. PubMed ID: 16178684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.